Evolutionary Dynamics of Mutator Phenotypes in Cancer: Implications for Chemotherapy

Cancer Research

Volumn 63, Issue 20, 2003, Pages 6635-6642

  Komarova, Natalia L ^a,b,c   Wodarz, Dominik ^d  

^a RUTGERS UNIVERSITY   (United States)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CELL CYCLE; DNA DAMAGE; DNA REPAIR; DYNAMICS; GENE MUTATION; GENETIC STABILITY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; DNA, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MODELS, GENETIC; NEOPLASMS;

EID: 0142219899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rouse, J., and Jackson, S. P. Interfaces between the detection, signaling, and repair of DNA damage. Science (Wash. DC), 297: 547-551, 2002.
2. Kolodner, R. D., Putnam, C. D., and Myung, K. Maintenance of genome stability in Saccharomyces cerevisiae. Science (Wash. DC), 297: 552-557, 2002.
3. Elledge, S. J. Cell cycle checkpoints: preventing an identity crisis. Science (Wash. DC), 274: 1664-1672, 1996.
4. Wassmann, K., and Benezra, R. Mitotic checkpoints: from yeast to cancer. Curr. Opin. Genet. Dev., 11: 83-90, 2001.
5. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human cancers. Nature (Lond.), 396: 643-649, 1998.
6. Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. When checkpoints fail. Cell, 88: 315-321, 1997.
7. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature (Lond.), 392: 300-303, 1998.
8. Myung, K., Chen, C., and Kolodner, R. D. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae. Nature (Lond.), 411: 1073-1076, 2001.
9. Dasika, G. K., Lin, S. C., Zhao, S., Sung, P., Tomkinson, A., and Lee, E. Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18: 7883-7899, 1999.
10. Dunican, D. S., McWilliam, P., Tighe, O., Parle-McDermott, A., and Croke, D. T. Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization. Oncogene, 21: 3253-3257, 2002.
11. Jackson, A. L., and Loeb, L. A. The mutation rate and cancer. Genetics, 148: 1483-1490, 1998.
12. Jackson, A. L., and Loeb, L. A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res., 477: 7-21, 2001.
13. Loeb, K. R., and Loeb, L. A. Significance of multiple mutations in cancer. Carcinogenesis (Lond.), 21: 379-385, 2000.
14. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51: 3075-3079, 1991.
15. Loeb, L. A. A mutator phenotype in cancer. Cancer Res., 61: 3230-3239, 2001.
16. Cahill, D. P., Kinzler, K. W., Vogelstein, B., and Lengauer, C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol., 9: M57-M60, 1999.
17. Breivik, J., and Gaudernack, G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin. Cancer Biol., 9: 245-254, 1999.
18. Breivik, J., and Gaudernack, G. Carcinogenesis and natural selection: a new perspective to the genetics and epigenetics of colorectal cancer. Adv. Cancer Res., 76: 187-212, 1999.
19. Cip1 inhibitor influences the outcome of the p53 response to DNA damage. Nature (Lond.), 419: 729-734, 2002.
20. Vogelstein, B., Lane, D., and Levine, A. J. Surfing the p53 network. Nature (Lond.), 408: 307-310, 2000.
21. Tomlinson, I. Different pathways of colorectal carcinogenesis and their clinical pictures. Ann. N. Y. Acad. Sci., 910: 10-18, discussion 18-20, 2000.
22. Tomlinson, I., and Bodmer, W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat. Med., 5: 11-12, 1999.
23. Tomlinson, I. P., Novelli, M. R., and Bodmer, W. F. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA. 93: 14800-14803, 1996.
24. Bardelli, A., Cahill, D. P., Lederer, G., Speicher, M. R., Kinzler, K. W., Vogelstein, B., and Lengauer, C. Carcinogen-specific induction of genetic instability. Proc. Natl. Acad. Sci. USA, 98: 5770-5775, 2001.
25. Nowak, M. A., Komarova, N. L., Sengupta, A., Jallepalli, P. V., Shih, I. M., Vogelstein, B., and Lengauer, C. The role of chromosomal instability in tumor initiation. Proc. Natl. Acad. Sci. USA, 99: 16226-16231, 2002.
26. Sancar, A. DNA repair in humans. Annu. Rev. Genet., 29: 69-105, 1995.
27. Middleton, M. R., and Margison, G. P. Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway. Lancet Oncol., 4: 37-44, 2003.
28. Lawrence, T. S., Blackstock, A. W., and McGinn, C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin. Radiat. Oncol., 13: 13-21, 2003.